Global Blood Therapeutics, Inc.·4

Mar 19, 4:10 PM ET

Thompson Alexis A. 4

4 · Global Blood Therapeutics, Inc. · Filed Mar 19, 2021

Insider Transaction Report

Form 4
Period: 2021-03-17
Transactions
  • Award

    Restricted Stock Units

    2021-03-17+7,2007,200 total
    Common Stock (7,200 underlying)
  • Award

    Stock Option (Right to Buy)

    2021-03-17+11,20011,200 total
    Exercise: $44.28Exp: 2031-03-16Common Stock (11,200 underlying)
Footnotes (2)
  • [F1]The shares of Common Stock underlying the option vest in 36 equal monthly installments after March 17, 2021, so long as the Reporting Person continues as a board member of the Issuer through each vesting date. This option is subject to accelerated vesting upon a change of control of the Issuer.
  • [F2]Each Restricted Stock Unit ("RSU") represents the right to receive one share of the Issuer's Common Stock. The shares of Common Stock underlying the RSUs vest in three equal annual installments after March 17, 2021, so long as the Reporting Person continues as a board member of the Issuer through each vesting date. The RSUs are subject to accelerated vesting upon a change of control of the Issuer.

Documents

1 file
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION